Log in
NASDAQ:ATRA

Atara Biotherapeutics News Headlines

$13.77
-0.24 (-1.71 %)
(As of 10/19/2020 12:00 AM ET)
Add
Compare
Today's Range
$13.76
Now: $13.77
$14.37
50-Day Range
$12.55
MA: $13.98
$15.87
52-Week Range
$4.52
Now: $13.77
$19.36
Volume373,567 shs
Average Volume1.06 million shs
Market Capitalization$1.02 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.04

Headlines

Atara Biotherapeutics (NASDAQ ATRA) News Headlines Today

Source:
DateHeadline
Atara Biotherapeutics (NASDAQ:ATRA) Receives "Buy" Rating from William BlairAtara Biotherapeutics (NASDAQ:ATRA) Receives "Buy" Rating from William Blair
marketbeat.com - September 24 at 6:07 AM
Atara Biotherapeutics (NASDAQ:ATRA) Downgraded by Zacks Investment ResearchAtara Biotherapeutics (NASDAQ:ATRA) Downgraded by Zacks Investment Research
marketbeat.com - August 11 at 5:34 PM
Atara Biotherapeutics (NASDAQ:ATRA) Stock Price Up 5.1%Atara Biotherapeutics (NASDAQ:ATRA) Stock Price Up 5.1%
americanbankingnews.com - October 15 at 7:21 PM
We Think Atara Biotherapeutics (NASDAQ:ATRA) Needs To Drive Business Growth CarefullyWe Think Atara Biotherapeutics (NASDAQ:ATRA) Needs To Drive Business Growth Carefully
finance.yahoo.com - September 22 at 7:37 AM
Stocks Showing Market Leadership: Atara Biotherapeutics Earns 92 RS RatingStocks Showing Market Leadership: Atara Biotherapeutics Earns 92 RS Rating
finance.yahoo.com - September 16 at 12:42 PM
Beyond Mesothelioma, Multiple Sclerosis Could Help Ataras Stock Soar ExponentiallyBeyond Mesothelioma, Multiple Sclerosis Could Help Atara's Stock Soar Exponentially
msn.com - September 15 at 4:41 PM
Atara (ATRA) Looks Good: Stock Adds 5.1% in SessionAtara (ATRA) Looks Good: Stock Adds 5.1% in Session
finance.yahoo.com - September 14 at 10:50 AM
Company News for Sep 14, 2020Company News for Sep 14, 2020
finance.yahoo.com - September 14 at 10:50 AM
Atara Biotherapeutics To Present Clinical Data in Epstein-Barr Virus-Driven (EBV+) Acquired & Primary Immunodeficiency Lymphoproliferative Diseases (AID-LPD and PID-LPD) from Tab-Cel® Expanded Access Program in e-Poster at ESMO 2020 Virtual CongressAtara Biotherapeutics To Present Clinical Data in Epstein-Barr Virus-Driven (EBV+) Acquired & Primary Immunodeficiency Lymphoproliferative Diseases (AID-LPD and PID-LPD) from Tab-Cel® Expanded Access Program in e-Poster at ESMO 2020 Virtual Congress
finance.yahoo.com - September 14 at 9:20 AM
Atara Bio Rises After Multiple Sclerosis Drug Shows Sustained ImprovementAtara Bio Rises After Multiple Sclerosis Drug Shows Sustained Improvement
finance.yahoo.com - September 13 at 8:58 AM
Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Improvement at 12 Months in the Phase ...Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Improvement at 12 Months in the Phase ...
businesswire.com - September 13 at 8:18 AM
Atara Bio lead candidate shows sustained benefit in MS patientsAtara Bio lead candidate shows sustained benefit in MS patients
seekingalpha.com - September 11 at 10:00 AM
Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Improvement at 12 Months in the Phase 1a Study of ATA188Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Improvement at 12 Months in the Phase 1a Study of ATA188
finance.yahoo.com - September 11 at 10:00 AM
Is a Viable Treatment for Mesothelioma on the Horizon?Is a Viable Treatment for Mesothelioma on the Horizon?
msn.com - September 9 at 12:33 PM
Atara Biotherapeutics Announces FDA Clearance of IND for ATA2271, a Next-Generation Autologous Mesothelin-Targeted CAR T with Novel PD1DNR and 1XX Technologies Combined to Treat Solid TumorsAtara Biotherapeutics Announces FDA Clearance of IND for ATA2271, a Next-Generation Autologous Mesothelin-Targeted CAR T with Novel PD1DNR and 1XX Technologies Combined to Treat Solid Tumors
finance.yahoo.com - September 8 at 8:15 AM
Atara Biotherapeutics to Present 12-Month Data from All Four Cohorts in the Phase 1a Study of ATA188 in Progressive Multiple Sclerosis at MSVirtual2020Atara Biotherapeutics to Present 12-Month Data from All Four Cohorts in the Phase 1a Study of ATA188 in Progressive Multiple Sclerosis at MSVirtual2020
finance.yahoo.com - September 1 at 7:45 AM
Did Hedge Funds Make The Right Call On Atara Biotherapeutics Inc (ATRA)Did Hedge Funds Make The Right Call On Atara Biotherapeutics Inc (ATRA)
finance.yahoo.com - August 12 at 1:15 PM
Did Hedge Funds Make The Right Call On Atara Biotherapeutics Inc (ATRA) ?Did Hedge Funds Make The Right Call On Atara Biotherapeutics Inc (ATRA) ?
finance.yahoo.com - August 12 at 10:19 AM
Atara Biotherapeutics Inc (ATRA) Q2 2020 Earnings Call TranscriptAtara Biotherapeutics Inc (ATRA) Q2 2020 Earnings Call Transcript
nasdaq.com - August 6 at 3:47 PM
Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q2 2020 Results - Earnings Call TranscriptAtara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 2:58 AM
Atara Biotherapeutics Announces Second Quarter 2020 Financial Results and Operational ProgressAtara Biotherapeutics Announces Second Quarter 2020 Financial Results and Operational Progress
finance.yahoo.com - August 5 at 4:57 PM
Assessing An Investment In Atara BiotherapeuticsAssessing An Investment In Atara Biotherapeutics
seekingalpha.com - August 4 at 2:50 PM
Why Atara Biotherapeutics (ATRA) Might Surprise This Earnings SeasonWhy Atara Biotherapeutics (ATRA) Might Surprise This Earnings Season
finance.yahoo.com - August 4 at 9:43 AM
Atara Biotherapeutics to Announce Second Quarter 2020 Financial Results on Wednesday, August 5, 2020Atara Biotherapeutics to Announce Second Quarter 2020 Financial Results on Wednesday, August 5, 2020
finance.yahoo.com - July 29 at 5:36 PM
Atara Biotherapeutics (ATRA) Moves to Buy: Rationale Behind the UpgradeAtara Biotherapeutics (ATRA) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - July 21 at 1:41 PM
Atara Biotherapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesAtara Biotherapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 24 at 7:29 PM
Hedge Funds Have Never Been This Bullish On Atara Biotherapeutics Inc (ATRA)Hedge Funds Have Never Been This Bullish On Atara Biotherapeutics Inc (ATRA)
finance.yahoo.com - June 23 at 11:51 PM
Is Atara Biotherapeutics (ATRA) Stock a Solid Choice Right Now?Is Atara Biotherapeutics (ATRA) Stock a Solid Choice Right Now?
finance.yahoo.com - June 23 at 1:51 PM
Atara up 4% on advancement of ATA188 in MS studyAtara up 4% on advancement of ATA188 in MS study
seekingalpha.com - June 17 at 12:49 PM
Atara Biotherapeutics Announces First Patient Enrolled in Randomized Placebo-Controlled Study of Allogeneic T-cell Therapy ATA188 in Progressive Forms of Multiple SclerosisAtara Biotherapeutics Announces First Patient Enrolled in Randomized Placebo-Controlled Study of Allogeneic T-cell Therapy ATA188 in Progressive Forms of Multiple Sclerosis
finance.yahoo.com - June 17 at 9:38 AM
Atara Biotherapeutics Announces its 2020 Annual Meeting of Stockholders Will Be Held on June 16, 2020 in Virtual FormatAtara Biotherapeutics Announces its 2020 Annual Meeting of Stockholders Will Be Held on June 16, 2020 in Virtual Format
finance.yahoo.com - June 5 at 6:20 PM
Atara Biotherapeutics to Participate at Two Upcoming ConferencesAtara Biotherapeutics to Participate at Two Upcoming Conferences
finance.yahoo.com - June 4 at 6:56 PM
Atara Bio prices $175.5M equity offeringAtara Bio prices $175.5M equity offering
seekingalpha.com - May 27 at 9:31 AM
Atara Biotherapeutics Announces Pricing of $175.5 Million Public OfferingAtara Biotherapeutics Announces Pricing of $175.5 Million Public Offering
finance.yahoo.com - May 27 at 9:31 AM
Atara Bio launches equity offeringAtara Bio launches equity offering
seekingalpha.com - May 26 at 6:14 PM
Atara Biotherapeutics Announces Proposed Offering of Common Stock and Pre-Funded WarrantsAtara Biotherapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
finance.yahoo.com - May 26 at 6:14 PM
Should Atara Bios Stock Volatility Consider Any Valuation at All on Multiple Sclerosis?Should Atara Bio's Stock Volatility Consider Any Valuation at All on Multiple Sclerosis?
247wallst.com - May 26 at 1:14 PM
Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late ...Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late ...
www.businesswire.com - May 26 at 8:14 AM
Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at the 2020 European Academy of Neurology Virtual CongressAtara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at the 2020 European Academy of Neurology Virtual Congress
finance.yahoo.com - May 26 at 8:14 AM
Atara Bio (+11%) cell therapy shows promising action in MS studyAtara Bio (+11%) cell therapy shows promising action in MS study
seekingalpha.com - May 22 at 5:48 PM
Thinking about buying stock in Atara Biotherapeutics, Anavex Life Sciences, Boxlight Corp, FuelCell Energy, or Upwork Inc?Thinking about buying stock in Atara Biotherapeutics, Anavex Life Sciences, Boxlight Corp, FuelCell Energy, or Upwork Inc?
www.prnewswire.com - May 21 at 10:11 AM
ATRA Abuzz, ATOS COVID-19 Med Effective, INO And VXRT On TrackATRA Abuzz, ATOS' COVID-19 Med Effective, INO And VXRT On Track
www.nasdaq.com - May 21 at 1:48 AM
Atara Biotherapeutics to Present Late-Breaking ATA188 Data in Progressive Multiple Sclerosis at 2020 European Academy of Neurology (EAN) Virtual CongressAtara Biotherapeutics to Present Late-Breaking ATA188 Data in Progressive Multiple Sclerosis at 2020 European Academy of Neurology (EAN) Virtual Congress
finance.yahoo.com - May 19 at 9:25 AM
Atara Biotherapeutics (ATRA) Moves to Strong Buy: Rationale Behind the UpgradeAtara Biotherapeutics (ATRA) Moves to Strong Buy: Rationale Behind the Upgrade
finance.yahoo.com - May 18 at 1:56 PM
Atara Biotherapeutics Announces Presentation of Late-Breaking Preclinical Data on ATA2271, a Next-Generation Autologous CAR T Immunotherapy Targeting Mesothelin, at the ...Atara Biotherapeutics Announces Presentation of Late-Breaking Preclinical Data on ATA2271, a Next-Generation Autologous CAR T Immunotherapy Targeting Mesothelin, at the ...
www.businesswire.com - May 15 at 2:14 PM
Atara Biotherapeutics Announces Presentation of Late-Breaking Preclinical Data on ATA2271, a Next-Generation Autologous CAR T Immunotherapy Targeting Mesothelin, at the American Association for Cancer Research (AACR) Virtual Annual Meeting II 2020Atara Biotherapeutics Announces Presentation of Late-Breaking Preclinical Data on ATA2271, a Next-Generation Autologous CAR T Immunotherapy Targeting Mesothelin, at the American Association for Cancer Research (AACR) Virtual Annual Meeting II 2020
finance.yahoo.com - May 15 at 2:14 PM
Why Atara Biotherapeutics (ATRA) Stock Might be a Great PickWhy Atara Biotherapeutics (ATRA) Stock Might be a Great Pick
finance.yahoo.com - May 13 at 10:23 AM
Atara Biotherapeutics Announces Appointment of Cell & Gene Therapy Expert Maria Grazia Roncarolo, MD to Board of DirectorsAtara Biotherapeutics Announces Appointment of Cell & Gene Therapy Expert Maria Grazia Roncarolo, MD to Board of Directors
finance.yahoo.com - May 11 at 6:13 PM
Will Atara Biotherapeutics Continue to Surge Higher?Will Atara Biotherapeutics Continue to Surge Higher?
finance.yahoo.com - May 11 at 3:35 PM
Edited Transcript of ATRA earnings conference call or presentation 6-May-20 8:30pm GMTEdited Transcript of ATRA earnings conference call or presentation 6-May-20 8:30pm GMT
finance.yahoo.com - May 7 at 3:21 PM
Atara Biotherapeutics Inc (ATRA) Q1 2020 Earnings Call TranscriptAtara Biotherapeutics Inc (ATRA) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 7 at 3:21 PM
Atara Biotherapeutics EPS beats by $0.23Atara Biotherapeutics EPS beats by $0.23
seekingalpha.com - May 7 at 1:16 AM
This page was last updated on 10/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.